231 related articles for article (PubMed ID: 25101846)
1. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Morote J; Celma A; Planas J; Placer J; de Torres I; Olivan M; Carles J; Reventós J; Doll A
Int J Mol Sci; 2014 Aug; 15(8):13615-23. PubMed ID: 25101846
[TBL] [Abstract][Full Text] [Related]
2. Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort.
Tang B; Han CT; Zhang GM; Zhang CZ; Yang WY; Shen Y; Vidal AC; Freedland SJ; Zhu Y; Ye DW
Sci Rep; 2017 Mar; 7():43551. PubMed ID: 28272469
[TBL] [Abstract][Full Text] [Related]
3. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
[TBL] [Abstract][Full Text] [Related]
4. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy.
Rantaniemi L; Tammela TLJ; Kujala P; Murtola TJ
Scand J Urol; 2018 Aug; 52(4):269-276. PubMed ID: 30362865
[TBL] [Abstract][Full Text] [Related]
5. The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.
Liang Y; Ketchum NS; Louden C; Jimenez-Rios MA; Thompson IM; Camarena-Reynoso HR
Urol Int; 2012; 89(1):9-16. PubMed ID: 22626812
[TBL] [Abstract][Full Text] [Related]
6. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
Joentausta RM; Rannikko A; Murtola TJ
Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
[TBL] [Abstract][Full Text] [Related]
8. Agent Orange as a risk factor for high-grade prostate cancer.
Ansbaugh N; Shannon J; Mori M; Farris PE; Garzotto M
Cancer; 2013 Jul; 119(13):2399-404. PubMed ID: 23670242
[TBL] [Abstract][Full Text] [Related]
9. Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.
Mondul AM; Selvin E; De Marzo AM; Freedland SJ; Platz EA
Cancer Causes Control; 2010 May; 21(5):671-8. PubMed ID: 20072809
[TBL] [Abstract][Full Text] [Related]
10. Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.
Wang K; Gerke TA; Chen X; Prosperi M
Cancer Med; 2019 Dec; 8(17):7399-7407. PubMed ID: 31595713
[TBL] [Abstract][Full Text] [Related]
11. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer.
Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J
Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042
[TBL] [Abstract][Full Text] [Related]
12. Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.
Allott EH; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Cancer Prev Res (Phila); 2017 Jun; 10(6):319-326. PubMed ID: 28487295
[TBL] [Abstract][Full Text] [Related]
13. Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.
Schnoeller TJ; Jentzmik F; Schrader AJ; Steinestel J
Oncotarget; 2017 Jul; 8(29):47110-47120. PubMed ID: 28445145
[TBL] [Abstract][Full Text] [Related]
14. Associations among statins, preventive care, and prostate cancer mortality.
Kumar A; Riviere P; Luterstein E; Nalawade V; Vitzthum L; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):475-485. PubMed ID: 32029930
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
[TBL] [Abstract][Full Text] [Related]
16. Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy.
Bañez LL; Klink JC; Jayachandran J; Lark AL; Gerber L; Hamilton RJ; Masko EM; Vollmer RT; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):722-8. PubMed ID: 20160265
[TBL] [Abstract][Full Text] [Related]
17. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer.
Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Klaassen Z; Chandrasekar T; Ahmad AE; Sayyid RK; Saarela O; Penn L; Alibhai SMH; Fleshner N
Eur Urol Focus; 2021 May; 7(3):537-545. PubMed ID: 32620539
[TBL] [Abstract][Full Text] [Related]
18. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
19. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population.
Fang D; Zhao C; Ren D; Yu W; Wang R; Wang H; Li X; Yin W; Yu X; Yang K; Liu P; Shan G; Li S; He Q; Wang X; Xin Z; Zhou L
Ann Surg Oncol; 2016 Dec; 23(13):4284-4292. PubMed ID: 27464612
[TBL] [Abstract][Full Text] [Related]
20. Statins and prostate cancer diagnosis and grade in a veterans population.
Farwell WR; D'Avolio LW; Scranton RE; Lawler EV; Gaziano JM
J Natl Cancer Inst; 2011 Jun; 103(11):885-92. PubMed ID: 21498780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
